Case Management for Blood Pressure and Lipid Level Control After Minor Stroke: PREVENTION Randomized Controlled Trial

Overview

Journal CMAJ

Date 2014 Apr 16

PMID 24733770

Citations 42

Authors

Finlay A McAlister

Sumit R Majumdar

Raj S Padwal

Miriam Fradette

Ann Thompson

Brian Buck

Naeem Dean

Jeffrey A Bakal

Ross Tsuyuki

Steven Grover

Ashfaq Shuaib

Affiliations

Soon will be listed here.

Abstract

Background: Optimization of systolic blood pressure and lipid levels are essential for secondary prevention after ischemic stroke, but there are substantial gaps in care, which could be addressed by nurse- or pharmacist-led care. We compared 2 types of case management (active prescribing by pharmacists or nurse-led screening and feedback to primary care physicians) in addition to usual care.

Methods: We performed a prospective randomized controlled trial involving adults with recent minor ischemic stroke or transient ischemic attack whose systolic blood pressure or lipid levels were above guideline targets. Participants in both groups had a monthly visit for 6 months with either a nurse or pharmacist. Nurses measured cardiovascular risk factors, counselled patients and faxed results to primary care physicians (active control). Pharmacists did all of the above as well as prescribed according to treatment algorithms (intervention).

Results: Most of the 279 study participants (mean age 67.6 yr, mean systolic blood pressure 134 mm Hg, mean low-density lipoprotein [LDL] cholesterol 3.23 mmol/L) were already receiving treatment at baseline (antihypertensives: 78.1%; statins: 84.6%), but none met guideline targets (systolic blood pressure ≤ 140 mm Hg, fasting LDL cholesterol ≤ 2.0 mmol/L). Substantial improvements were observed in both groups after 6 months: 43.4% of participants in the pharmacist case manager group met both systolic blood pressure and LDL guideline targets compared with 30.9% in the nurse-led group (12.5% absolute difference; number needed to treat = 8, p = 0.03).

Interpretation: Compared with nurse-led case management (risk factor evaluation, counselling and feedback to primary care providers), active case management by pharmacists substantially improved risk factor control at 6 months among patients who had experienced a stroke.

Trial Registration: ClinicalTrials.gov, no. NCT00931788.

Citing Articles

The effect of clinical pharmacist-led pharmaceutical care services on medication adherence, clinical outcomes and quality of life in patients with stroke: a randomised controlled trial.

Cengiz K, Midi I, Sancar M Int J Clin Pharm. 2024; 47(1):99-106.

PMID: 39395139 DOI: 10.1007/s11096-024-01811-0.

Stroke Risk Reduction in Atrial Fibrillation Through Pharmacist Prescribing: A Randomized Clinical Trial.

Sandhu R, Fradette M, Lin M, Youngson E, Lau D, Bungard T JAMA Netw Open. 2024; 7(7):e2421993.

PMID: 39046741 PMC: 11270136. DOI: 10.1001/jamanetworkopen.2024.21993.

Improving Patient-Reported Outcomes in Stroke Care using Remote Blood Pressure Monitoring and Telehealth.

Naqvi I, Strobino K, Li H, Schmitt K, Barratt Y, Ferrara S Appl Clin Inform. 2023; 14(5):883-891.

PMID: 37940129 PMC: 10632067. DOI: 10.1055/s-0043-1772679.

Effects of a Computerized Prescriber Order Entry System on Pharmacist Prescribing.

Metzger S, Evernden C, Bungard T, Bell G, Omar M Can J Hosp Pharm. 2023; 76(2):102-108.

PMID: 36998758 PMC: 10049774. DOI: 10.4212/cjhp.3302.

Stroke services in the Middle East and adjacent region: A survey of 34 hospital-based stroke services.

Al Hashmi A, Shuaib A, Imam Y, Amr D, Humaidan H, Al Nidawi F Front Neurol. 2022; 13:1016376.

PMID: 36408502 PMC: 9667787. DOI: 10.3389/fneur.2022.1016376.

References

Kerry S, Markus H, Khong T, Cloud G, Tulloch J, Coster D . Home blood pressure monitoring with nurse-led telephone support among patients with hypertension and a history of stroke: a community-based randomized controlled trial. CMAJ. 2012; 185(1):23-31. PMC: 3537777. DOI: 10.1503/cmaj.120832. View

Joseph L, Babikian V, Allen N, Winter M . Risk factor modification in stroke prevention: the experience of a stroke clinic. Stroke. 1999; 30(1):16-20. DOI: 10.1161/01.str.30.1.16. View

Straus S, Majumdar S, McAlister F . New evidence for stroke prevention: scientific review. JAMA. 2002; 288(11):1388-95. DOI: 10.1001/jama.288.11.1388. View

Law M, Morris J, Wald N . Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338:b1665. PMC: 2684577. DOI: 10.1136/bmj.b1665. View

Baigent C, Keech A, Kearney P, Blackwell L, Buck G, Pollicino C . Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366(9493):1267-78. DOI: 10.1016/S0140-6736(05)67394-1. View

Margolis K, Asche S, Bergdall A, Dehmer S, Groen S, Kadrmas H . Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013; 310(1):46-56. PMC: 4311883. DOI: 10.1001/jama.2013.6549. View

Carter B, Rogers M, Daly J, Zheng S, James P . The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009; 169(19):1748-55. PMC: 2882164. DOI: 10.1001/archinternmed.2009.316. View

McAlister F, Majumdar S, Padwal R, Fradette M, Thompson A, Tsuyuki R . The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrials.gov identifier: NCT00931788]. Implement Sci. 2010; 5:27. PMC: 2868046. DOI: 10.1186/1748-5908-5-27. View

Glynn L, Murphy A, Smith S, Schroeder K, Fahey T . Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010; (3):CD005182. DOI: 10.1002/14651858.CD005182.pub4. View

10.

Majumdar S, McAlister F, Furberg C . From knowledge to practice in chronic cardiovascular disease: a long and winding road. J Am Coll Cardiol. 2004; 43(10):1738-42. DOI: 10.1016/j.jacc.2003.12.043. View

11.

McLean D, McAlister F, Johnson J, King K, Makowsky M, Jones C . A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008; 168(21):2355-61. DOI: 10.1001/archinte.168.21.2355. View

12.

Santschi V, Chiolero A, Burnand B, Colosimo A, Paradis G . Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011; 171(16):1441-53. DOI: 10.1001/archinternmed.2011.399. View

13.

Hackam D, Spence J . Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007; 38(6):1881-5. DOI: 10.1161/STROKEAHA.106.475525. View

14.

Bhatt D, Steg P, Ohman E, Hirsch A, Ikeda Y, Mas J . International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006; 295(2):180-9. DOI: 10.1001/jama.295.2.180. View

15.

Ellis G, Rodger J, McAlpine C, Langhorne P . The impact of stroke nurse specialist input on risk factor modification: a randomised controlled trial. Age Ageing. 2005; 34(4):389-92. DOI: 10.1093/ageing/afi075. View

16.

Rothwell P, Giles M, Chandratheva A, Marquardt L, Geraghty O, Redgrave J . Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007; 370(9596):1432-42. DOI: 10.1016/S0140-6736(07)61448-2. View

17.

ODonnell M, Xavier D, Liu L, Zhang H, Chin S, Rao-Melacini P . Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010; 376(9735):112-23. DOI: 10.1016/S0140-6736(10)60834-3. View

18.

Mouradian M, Majumdar S, Senthilselvan A, Khan K, Shuaib A . How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack?. Stroke. 2002; 33(6):1656-9. DOI: 10.1161/01.str.0000017877.62543.14. View

19.

Webster F, Saposnik G, Kapral M, Fang J, OCallaghan C, Hachinski V . Organized outpatient care: stroke prevention clinic referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke. Stroke. 2011; 42(11):3176-82. DOI: 10.1161/STROKEAHA.111.621524. View

20.

Amarenco P, Goldstein L, Szarek M, Sillesen H, Rudolph A, Callahan 3rd A . Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007; 38(12):3198-204. DOI: 10.1161/STROKEAHA.107.493106. View